Page last updated: 2024-08-24

ranolazine and isosorbide-5-mononitrate

ranolazine has been researched along with isosorbide-5-mononitrate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bueno, O; Zavecz, JH1
Dixit, D; Kimborowicz, K1
Crea, F; De Vita, A; Di Franco, A; Golino, M; Lamendola, P; Lanza, GA; Manfredonia, L; Melita, V; Mencarelli, E; Spera, FR; Villano, A1
Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH1

Reviews

2 review(s) available for ranolazine and isosorbide-5-mononitrate

ArticleYear
Pharmacologic therapy of angina pectoris.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1995, Volume: 147, Issue:5

    Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents

1995
Pharmacologic management of chronic stable angina.
    JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents

2015

Trials

2 trial(s) available for ranolazine and isosorbide-5-mononitrate

ArticleYear
Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:19

    Topics: Aged; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Cross-Over Studies; Female; Humans; Isosorbide Dinitrate; Male; Microcirculation; Microvessels; Middle Aged; Percutaneous Coronary Intervention; Ranolazine; Rome; Single-Blind Method; Time Factors; Treatment Outcome; Vasodilator Agents

2018
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
    Journal of the American Heart Association, 2021, 02-02, Volume: 10, Issue:3

    Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents

2021